Hong Kong at a glance
- Population
- 7.5 million 2025
- Life expectancy at birth
- 85.4 years, 2024
- People aged 65 and over
- 23.7 % of people, 2025
Updated
Reviewed by Vidhi Upadhyay
Hong Kong Calcium supplements Market Industry Trends and Forecast to 2034: Segmented by (Application, Type, Form, End User) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$3.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $4.3 Mn | — | — |
| 2025 (base) | $4.6 Mn | +$0.3 Mn | — |
| 2026 (forecast) | $4.9 Mn | +$0.3 Mn | +7% |
| 2027 (forecast) | $5.2 Mn | +$0.3 Mn | +14.5% |
| 2028 (forecast) | $5.6 Mn | +$0.4 Mn | +22.5% |
| 2029 (forecast) | $6.0 Mn | +$0.4 Mn | +31.1% |
| 2030 (forecast) | $6.4 Mn | +$0.4 Mn | +40.3% |
| 2031 (forecast) | $6.9 Mn | +$0.4 Mn | +50.1% |
| 2032 (forecast) | $7.4 Mn | +$0.5 Mn | +60.6% |
| 2033 (forecast) | $7.9 Mn | +$0.5 Mn | +71.8% |
| 2034 (forecast) | $8.4 Mn | +$0.6 Mn | +83.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $4.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $8.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Application, type, form and end user (see all) |
| Key players | Caltrate, Citracal, GSK PLC, High Change, Kirkland and 5 more (see all) |
| Regulator in Hong Kong | Drug Office and Centre for Food SafetySource: Drug Office, Department of Health. Checked 14 Nov 2026.Source: Centre for Food Safety. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Calcium supplements are dietary products designed to provide additional calcium, an essential mineral crucial for various bodily functions, particularly bone health. Calcium is vital for the development, maintenance, and strength of bones and teeth, as well as for muscle function, nerve transmission, and blood clotting. While calcium can be obtained through dietary sources such as dairy products, leafy greens, and fortified foods, supplements may be recommended for individuals who have difficulty meeting their calcium needs through diet alone.
Globally, the scenario for calcium supplements reflects a significant awareness of their importance in preventing osteoporosis and maintaining bone health, especially among older adults and postmenopausal women. Research indicates that approximately 40% of women over 50 in the United States take calcium supplements to help reduce the risk of bone density loss. The increasing prevalence of osteoporosis worldwide underscores the need for adequate calcium intake; studies show that calcium supplementation can effectively improve bone mineral density in at-risk populations. However, there are concerns regarding excessive calcium intake and its potential association with cardiovascular risks. As a result, while adoption rates for calcium supplements are high, it is essential for consumers to seek guidance on appropriate dosages and to consider dietary sources first to achieve optimal health outcomes
The adoption of calcium supplements is positively influenced by the increasing recognition of their importance in preventing osteoporosis and supporting overall bone health, particularly among at-risk populations such as older adults and postmenopausal women. Research indicates that adequate calcium intake is crucial for maintaining bone density, with studies showing that supplementation can significantly reduce the risk of fractures. For instance, a systematic review highlighted that calcium supplementation effectively increases bone mineral density in individuals with low dietary calcium intake. Furthermore, public health initiatives and educational campaigns aimed at raising awareness about the benefits of calcium have contributed to higher adoption rates. The availability of various supplement forms—such as chewable tablets and capsules—enhances accessibility and compliance, making it easier for consumers to incorporate these supplements into their daily routines.
There has been a rise in educational campaigns targeted at increasing consumer knowledge on the health benefits of calcium which has a created an opportunity for the calcium supplement market to attract new customers. The rise in novel calcium supplementation products like gummies has allowed this market to offer another way to include calcium into the daily lives of consumers. Another promising opportunity is the growing demand of increasing the use of calcium formate in animal feed. This new application type is set to contribute to the increased growth of the calcium supplementation.
The adoption of calcium supplements faces several challenges. One significant issue is the prevalence of misinformation about their safety and efficacy. Research suggests that excessive calcium intake may be associated with cardiovascular risks, fostering skepticism among consumers regarding the necessity of supplementation. Moreover, many individuals are unaware of their dietary deficiencies or lack understanding of the recommended daily calcium intake. Studies show that lower education levels often correlate with limited knowledge about the benefits of calcium, further hindering adoption rates. Cultural beliefs and social influences also play a role, as some communities prioritize dietary sources over supplements.
A major development of the calcium supplement market is corporations producing new calcium tablets that include a variety of other vitamins like Vitamin D, magnesium, zinc and Vitamin K among others. Companies like Immunosciences have even developed gummies that are 100% vegetarian allowing them to cater to an even larger market base.
In February 2020 Itibanyl Produtos Especias Ltda(IPEL) was acquired by LANXESS.
In May 2022 Calcium Capital acquired a minority stake in Equance a wealth management firm.
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.[1] Health supplements are generally regulated as food, overseen by the Centre for Food Safety; proprietary Chinese medicines must be registered with the Chinese Medicine Council.[2]
[1] Drug Office, Department of Health. Checked 14 Nov 2026.
[2] Centre for Food Safety. Checked 14 Nov 2026.
Different countries have varied regulatory laws round calcium supplementation. This makes it difficult for companies to launch new products simultaneously in different regions. For example the FDA of the United States has set a limit of the amount of calcium lead that a supplement product can contain however this law does not apply across other regulatory bodies. Additionally the growing trend of natural supplements has encourages regulatory bodies to begin to adjust their laws to cater to these new products which may have an influence on the ingredients used in developing their supplements.
What doctors and scientists are doing in Calcium Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 1 shared keyword
Hong Kong · 1 shared keyword
Hong Kong · 1 shared keyword
Hong Kong · 1 shared keyword
Digital Health · Hong Kong
Medical Devices · Hong Kong
Pharmaceuticals · Hong Kong
Pharmaceuticals · Hong Kong
Healthcare Services · Hong Kong
Pharmaceuticals · Hong Kong